Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Market Chatter: Morgan Stanley Launches $2.3 Billion Baldwin Debt Offering

Market Chatter: Morgan Stanley Launches $2.3 Billion Baldwin Debt Offering

MT newswireMT newswire2026/11/03 16:28
12:28 PM EST, 11/03/2026 (MT Newswires) -- Morgan Stanley (MS) has launched a $2.3 billion debt offering to help finance the acquisition of Baldwin Insurance Group by Michael Dell's family office and Sequence Holdings, Bloomberg reported Tuesday, citing a person familiar with the matter. The financing includes a $2 billion term loan and a $300 million delayed-draw term loan, both with seven-year maturities. Pricing is being discussed at 3.5 percentage points over the benchmark rate and 99 cents on the dollar, the report said. The acquisition financing also includes $750 million of privately placed second-lien secured debt. The $7.7 billion all-cash deal is expected to close in Q1 2027, Bloomberg reported. Morgan Stanley did not immediately respond to MT Newswires' request for comment. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 185.20, Change: -0.53, Percent Change: -0.29
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny